Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2003
09/04/2003CA2471646A1 Processes and intermediates useful in preparing .beta.3-adrenergic receptor agonists
09/04/2003CA2467833A1 Pharmaceutical compositions in particulate form
09/04/2003CA2465854A1 Compounds useful in the treatment of anthrax
09/04/2003CA2444940A1 Process for the production of citalopram
09/03/2003EP1340815A2 Determination of alpha-N-acetylgalactosaminidase activity
09/03/2003EP1340765A2 Inverted chimeric and hybrid oligonucleotides
09/03/2003EP1340759A1 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives
09/03/2003EP1340757A1 1-methylcarbapenem derivatives
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1340752A1 Process for the production of semi synthetic statins via novel intermediates
09/03/2003EP1340749A1 Isoxazole derivatives
09/03/2003EP1340745A1 Indirubin derivatives and their use for the treatment of cancer
09/03/2003EP1340744A2 Hiv protease inhibitors
09/03/2003EP1340510A1 Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
09/03/2003EP1340509A1 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
09/03/2003EP1340508A1 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
09/03/2003EP1340506A1 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties
09/03/2003EP1340505A2 Therapeutic use of cis-element decoys in vivo
09/03/2003EP1340504A1 Remedies for diabetes
09/03/2003EP1340503A1 Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
09/03/2003EP1340502A2 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
09/03/2003EP1340501A1 Beautifying foods and drinks and peroral beautifying preparations
09/03/2003EP1340500A1 Antidiabetic agents
09/03/2003EP1340499A1 Nootropic effect enhancer
09/03/2003EP1340498A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/03/2003EP1340497A1 Self emulsifying drug delivery systems for poorly soluble drugs
09/03/2003EP1340496A1 Pharmaceutical preparation of percutaneous absorption type
09/03/2003EP1340495A1 Extended release formulations of erythromycin derivatives
09/03/2003EP1340492A1 Aerosol formulations for pulmonary administration of medicaments having systemic effects
09/03/2003EP1340486A1 Use of sugar esters
09/03/2003EP1340431A1 Composition with xylitol and fiber, for use in foodstuffs and/or beverages
09/03/2003EP1339862A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol
09/03/2003EP1339844A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339754A1 Multicomponent compositions containing chitosan and methods of preparing same
09/03/2003EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus
09/03/2003EP1339730A2 Macrolide solvates
09/03/2003EP1339725A2 Dna methyl transferase inhibitors
09/03/2003EP1339721A2 Hydroxyesters of 7-desmethylrapamycin
09/03/2003EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof
09/03/2003EP1339717A1 Novel carbamate-substituted pyrazolopyridine derivatives
09/03/2003EP1339716A1 Novel lactame-substituted pyrazolopyridine derivatives
09/03/2003EP1339715A2 Heterocyclic ether substituted imidazoquinolines
09/03/2003EP1339714A1 Novel sulfonamide-substituted pyrazolopyridine derivatives
09/03/2003EP1339713A2 Saframycins, analogues and uses thereof
09/03/2003EP1339712A1 3-substituted quinuclidines and their use as nicotinic agonists
09/03/2003EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists
09/03/2003EP1339710A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives
09/03/2003EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
09/03/2003EP1339708A2 Indole-type inhibitors of p38 kinase
09/03/2003EP1339707A2 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
09/03/2003EP1339706A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339703A1 A process for the preparation of paclitaxel
09/03/2003EP1339702A1 5-amide substituted diarylamines as mek inhibitors
09/03/2003EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
09/03/2003EP1339698A2 Pyrimidine derivatives
09/03/2003EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands
09/03/2003EP1339695A1 Farnesyltransferase inhibitors
09/03/2003EP1339694A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
09/03/2003EP1339692A1 Novel compounds for use as hiv protease inhibitors
09/03/2003EP1339691A1 Novel compounds
09/03/2003EP1339690A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339689A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339688A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
09/03/2003EP1339686A2 Cyanoguanidine prodrugs
09/03/2003EP1339685A2 Biphenylcarboxamides useful as lipid lowering agents
09/03/2003EP1339684A1 Mch antagonists and their use in the treatment of obesity
09/03/2003EP1339683A2 Estrogen receptor modulators
09/03/2003EP1339682A1 1,4-disubstituted piperazine derivatives useful as uro-selective $g(a)1-adrenoceptor blockers
09/03/2003EP1339680A1 Substituted oxindole derivatives as tyrosine kinase inhibitors
09/03/2003EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists
09/03/2003EP1339678A2 Ep4 receptor selective agonists in the treatment of osteoporosis
09/03/2003EP1339677A1 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis
09/03/2003EP1339675A1 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds
09/03/2003EP1339673A1 Malonamide and malonamic ester derivatives with antithrombotic activity, their preparation and their use
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339669A2 N-alkylated gaba compounds, processes for their preparation and their use as medicaments
09/03/2003EP1339668A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/03/2003EP1339665A1 Nitroderivatives as drugs for diseases having an inflammatory basis
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP1339662A1 Novel estrogen receptor ligands and methods iii
09/03/2003EP1339458A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity
09/03/2003EP1339440A1 An implantable or insertable therapeutic agent delivery device
09/03/2003EP1339438A2 Methods for preventing transplant rejection in the eye
09/03/2003EP1339432A1 Molecular inclusion compounds consisting of biocatalytically obtained, linear, water-insoluble polysaccharides and of fatty acids or their derivatives
09/03/2003EP1339430A1 Freeze-dried pantoprazole preparation and pantoprazole injection
09/03/2003EP1339429A2 Composition containing statins and calcium for improved cardiovascular health
09/03/2003EP1339419A1 Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa
09/03/2003EP1339416A1 Trace elements
09/03/2003EP1339415A1 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
09/03/2003EP1339414A2 L-histidine in ophthalmic solutions
09/03/2003EP1339413A1 Complexes of phosphate derivatives
09/03/2003EP1339412A1 Formulation containing phosphate derivatives of electron transfer agents
09/03/2003EP1339411A2 Use of bisphosphonates for pain treatment
09/03/2003EP1339410A1 Use of pyrazolo 4,3-d]pyrimidines
09/03/2003EP1339409A1 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
09/03/2003EP1339408A1 Drug formulation having improved oral tolerability
09/03/2003EP1339407A1 Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease
09/03/2003EP1339406A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders
09/03/2003EP1339405A1 Use of anti-muscarinic agents and calcium channel blockers in combination
1 ... 5355 5356 5357 5358 5359 5360 5361 5362 5363 5364 5365 5366 5367 5368 5369 5370 5371 5372 5373 5374 5375 ... 7860